Identifying real time surveillance indicators to estimate COVID-19 hospital admissions in Colorado during and after the public health emergency.

Publication date: Jul 01, 2025

Questions remain about how best to focus surveillance efforts for COVID-19 and other emerging respiratory diseases. We used an archive of COVID-19 data in Colorado from October 2020 to March 2024 to reconstruct seven real-time surveillance indicators. We assessed how well the indicators predicted 7-day average COVID-19 hospital admissions, a key indicator of outbreak severity, using machine learning and regression models, and used cross-correlation analysis to identify leading indicators. We found that hospital-based surveillance metrics, including real-time hospital census data and emergency-department based syndromic surveillance, were among the best predictors of COVID-19 hospital admissions during and after the public health emergency (PHE). While wastewater was a weaker individual predictor, its removal from our multi-indicator models resulted in a decrease in model performance, suggesting that wastewater provides important, unique information. Likewise, we found that test positivity, while imprecise, can serve as a leading indicator of COVID-19 hospitalizations. These findings suggest hospital-based reporting should be a surveillance priority, and that wastewater surveillance and test positivity can improve situational awareness for COVID-19 in Colorado. In contrast, case reporting was not found to be essential to real-time monitoring of COVID-19 hospitalizations in Colorado. The generalizability to other regions and respiratory illnesses warrants further investigation.

Open Access PDF

Concepts Keywords
Colorado Colorado
Covid COVID-19
Hospitalizations COVID-19
October Emergency Service, Hospital
Surveillance Epidemiology
Hospitalization
Humans
Infectious disease
Neural network models
Pandemic preparedness
Patient Admission
Public Health
Public Health Surveillance
SARS-CoV-2
Surveillance

Semantics

Type Source Name
disease MESH COVID-19
disease MESH emergency
disease MESH respiratory diseases
drug DRUGBANK L-Phenylalanine
disease MESH Long Covid
disease MESH Infectious disease
pathway REACTOME Infectious disease
drug DRUGBANK Coenzyme M
disease MESH virus shedding
disease MESH infections
disease MESH asymptomatic infections
disease MESH respiratory infections
disease IDO process
disease IDO symptom
drug DRUGBANK Flunarizine
disease IDO algorithm
drug DRUGBANK Aspartame
drug DRUGBANK Ranitidine
disease MESH morbidity
disease MESH influenza
drug DRUGBANK Water
drug DRUGBANK Abacavir
drug DRUGBANK Acetylcholine
pathway REACTOME Reproduction

Original Article

(Visited 3 times, 1 visits today)